ArticleBioinformatics advances2025
PerseuCPP: a machine learning strategy to predict cell-penetrating peptides and their uptake efficiency.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Membrane-Traversing Peptides: Mechanistic Landscapes, Assays, and Applications.Chemical reviews · 2026Review
- SSEL-CPP: A SHAP-based feature-selection ensemble learning framework identifies molecular properties of cell-penetrating peptides.Protein science : a publication of the Protein Society · 2026Article
- Integrative Peptide Drug Development: Chemical Engineering, AI-Driven Design, and Cell-Penetrating Peptides.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Cell-penetrating peptides (CPPs) are promising tools for transporting therapeutic molecules into cells without damaging the cellular membrane. These peptides serve as efficient drug delivery systems, capable of carrying diverse biologically active substances while exhibiting low cytotoxicity compared to non-native molecules. However, identifying CPPs through experimental methods is expensive and time-consuming, making computational strategies an attractive alternative due to their cost-effectiveness and scalability. Results: This study introduces PerseuCPP, a machine learning strategy designed to identify CPPs. Based on descriptors including physicochemical and structural properties as well as atomic composition, our strategy employs the Extremely Randomized Trees to predict CPPs and their uptake efficiency. The first stage was developed using a balanced dataset of 967 CPPs and non-CPPs, applying a 10-fold cross-validation scheme. Two independent datasets were utilized for validation. The CPP predictor achieved superior results compared to state-of-the-art methods, with MCC 0.854, Recall 0.860, and AUC 0.984. The second stage, focused on efficiency prediction, was trained on a balanced dataset of 140 CPPs and non-CPPs, also using a 10-fold cross-validation scheme, and validated with an independent dataset. The efficiency predictor achieved competitive results, with Recall 0.761 and AUC 0.690. PerseuCPP is interpretable, offering insights into the key descriptors enabling peptides to penetrate cells effectively. We anticipate that PerseuCPP will be a valuable tool for advancing the design and application of CPPs in drug delivery and biomedical research. Availability and implementation: https://github.com/goalmeida05/PERSEU.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.